Ocular development after highly effective modulator treatment early in life

Highly effective cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulator therapies (HEMT), including elexacaftor-tezacaftor-ivacaftor, correct the underlying molecular defect causing CF. HEMT decreases general symptom burden by improving clinical metrics and quality of life for mos...

全面介紹

書目詳細資料

發表在:	Frontiers in Pharmacology
Main Authors:	Yimin Zhu, Danni Li, Felisa Reyes-Ortega, Holly R. Chinnery, Elena K. Schneider-Futschik
格式:	Article
語言:	英语
出版:	Frontiers Media S.A. 2023-09-01
主題:	cystic fibrosis ocular development CFTR modulator catarat eye malformations
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1265138/full